Țară: Regatul Unit
Limbă: engleză
Sursă: MHRA (Medicines & Healthcare Products Regulatory Agency)
Pericyazine
Zentiva Pharma UK Ltd
N05AC01
Pericyazine
2mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04020100; GTIN: 5000283653752
1 PACKAGE LEAFLET: INFORMATION FOR THE USER PERICYAZINE 10MG/5ML SYRUP READ ALL OF THIS LEAFL ET CAREFULLY BEFORE YOU TAKE THIS MEDICINE • Keep this leafl et. You may need to read it again • If you have any further questions, ask your doctor or pharmacist • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours • If any of the side eff ects gets serious, or if you notice any side eff ects not listed in this leafl et, please tell your doctor or pharmacist IN THIS LEAFL ET: 1. What pericyazine is and what it is used for 2. Before you take pericyazine 3. How to take pericyazine 4. Possible side eff ects 5. How to store pericyazine 6. Further Information 1. WHAT PERICYAZINE IS AND WHAT IT IS USED FOR The name of your medicine is Pericyazine 10mg/5ml Syrup (referred to as pericyazine throughout this leafl et). This belongs to a group of medicines called ‘phenothiazines’. It works by blocking the eff ect of a chemical in the brain. It can be used for: ADULTS • Schizophrenia • The short term treatment of anxiety, agitation and violent or dangerously impulsive behaviour when used with other medicines CHILDREN • Schizophrenia • Other behavioural problems 2. BEFORE YOU TAKE PERICYAZINE DO NOT TAKE THIS MEDICINE AND TELL YOUR DOCTOR IF: You are allergic (hypersensitive) to pericyazine or any of the other ingredients in this medicine (listed in Section 6) Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking pericyazine. TAKE SPECIAL CARE WITH PERICYAZINE CHECK WITH YOUR DOCTOR OR PHARMACIST BEFORE YOU TAKE THIS MEDICINE IF: ▲You have liver or kidney problems ▲You have thyroid problems ▲You have heart problems or a family history of heart problems ▲You have ever had a stroke ▲You have Parkinson’s disease ▲You h Citiți documentul complet
OBJECT 1 PERICYAZINE 10MG/5ML SYRUP Summary of Product Characteristics Updated 26-Oct-2017 | Zentiva 1. Name of the medicinal product Pericyazine 10mg/5ml Syrup 2. Qualitative and quantitative composition Pericyazine 10mg/5ml 3. Pharmaceutical form Syrup for oral administration 4. Clinical particulars 4.1 Therapeutic indications a) In adults with schizophrenia or other psychoses, for the treatment of symptoms or prevention of relapse. b) In anxiety, psychomotor agitation, violent or dangerously impulsive behaviour. Pericyazine is used as an adjunct to the short-term management of these conditions. c) In children with behaviour disorders or schizophrenia 4.2 Posology and method of administration Route of administration: oral Dosage requirement varies with the individual and the severity of the condition being treated. Initial dosage should be low with progressive increases until the desired response is obtained, after which dosage should be adjusted to maintain control of the symptoms. _Severe conditions_ INDICATIONS (A) OR (C) Adults Initially 75mg per day in divided doses. Dosage should be increased by 25mg per day at weekly intervals until the optimum effect is achieved. Maintenance therapy would not normally be expected to exceed 300mg per day. Elderly Initially 15-30mg per day in divided doses. If this is well tolerated the dosage may be increased if necessary for optimum control of behaviour. Children The initial daily dose should be calculated on bodyweight. A child weighing 10kg should receive 0.5 milligram and this initial dose should be increased by 1mg for each additional 5kg of bodyweight up to a total daily dose of 10mg daily. This dosage may be gradually increased until the desired effect is achieved, but the daily maintenance dose should not exceed twice the initial amount. Pericyazine is not recommended for use in children below 1 year of age. _Mild or moderate conditions_ ANXIETY, PSYCHMOTOR AGITATION, VIOLENT OR DANGEROUSLY IMPULSIVE BEHAVIOUR. Adults Initially 15-30mg daily, divided into two por Citiți documentul complet